Beyond Men: Viagra Cream for Female Sexual Arousal Disorder and Its Psychological Benefits

The topical treatment works by increasing blood

• Viagra cream can provide localized effects on erectile tissue.
• It might offer quicker results than oral medications.
• Some products claim longer-lasting erections with topical use.
• Topical application reduces the risk of some systemic adverse effects.
• Efficacy reports are anecdotal; clinical trials are limited.
• Proper application involves a gentle massage into the skin.
• Dosage instructions are essential for safety and effectiveness.
• Not recommended for use by women or children.
• Some products may contain unverified or unsafe ingredients.
• Always verify the legitimacy of the product before purchase.

flow in the vagina, improving sensation and arousal.

Conclusion: Healing, Not Just Heat

Your pelvic floor is a lot like plumbing in your home: you never really think about it unless something goes wrong. When you think of male sexual dysfunction, concerns like erectile dysfunction (ED) or premature ejaculation (PE) probably come to mind first. But there’s another sex-related issue that’s more common in men than you might expect: difficulty orgasming. Female sexual arousal disorder (FSAD) FSAD, as described in the Diagnostic and Statistical Manual 4th Edition (DSM-IV), is a condition characterized as a persistent or recurrent inability to attain or maintain sufficient genital arousal (an adequate lubrication-swelling response) during sexual activity, frequently resulting in distress or interpersonal difficulty. Of the various types of female sexual dysfunction disorders, FSAD is most analogous to erectile dysfunction viagra 100mg (ED) in men.

About the pre-fulfillment prescription period.

There are currently no FDA-approved therapies for FSAD. A meta-analysis of 95 studies from 2000-2014 indicated prevalence of Female Sexual Dysfunction in premenopausal women worldwide is 41%, and difficulty with arousal alone is 23%.1 Market research estimates: 33% of US women aged 21 to 60 (~ 20 million women), experience symptoms of low or no sexual arousal.2,310 million women in the US are considered distressed and actively seeking treatment.2 33% of US women aged 21 to 60 (~ 20 million women), experience symptoms of low or no sexual arousal.2,3 10 million women in the US are considered distressed and actively seeking treatment.2 To put the market opportunity for an FDA-approved FSAD treatment in context, a PDE5 inhibitor utilized in an ED medication for men – Viagra® — peaked at $2.05 billion in sales in 2012.4 Orally administered sildenafil, a phosphodiesterase-5 (PDE-5) inhibitor, received FDA approval in 1998 for the treatment of erectile dysfunction in men and is marketed under the brand name Viagra®. Given the underlying pathophysiologic similarities of ED and FSAD, using sildenafil to direct blood to the genitals before sexual activity could provide a potential improvement in genital arousal response and overall sexual experience for women as it does in men. Sildenafil Cream, 3.6% is an investigational proprietary topical formulation of sildenafil being developed as a first-in-category option for women for the treatment of FSAD. Unlike the oral formulations of PDE-5 inhibitors, Sildenafil Cream is applied locally to the vaginal tissue and is designed to facilitate vasodilation and increased blood flow directly to the genital tissue to improve the physical arousal response symptoms commonly associated with FSAD while avoiding systemic side effects observed with oral formulations of sildenafil. “We have this scientific evidence that

• Viagra cream might be preferred for its quick onset.
• It allows for discreet use without oral ingestion.
• Not advisable for use with alcohol or recreational drugs.
• Check for allergies to components before use.
• Effects typically last for around 1-2 hours.
• It should be applied to clean, dry skin.
• Enhancers or additional lubricants may improve effectiveness.
• It is advisable to consult a doctor concerning underlying health issues.
• Read and follow all instructions carefully.
• Be aware of potential counterfeit or substandard products.

sildenafil as an active ingredient can

Product	Dosage	Quantity + Bonus	Price
Viagra Generic	100mg	360 + 10 Pills	330.21€ 314.49€	Buy
Viagra Generic	150mg	180 + 10 Pills	236.46€ 225.20€	Buy
Viagra Super Active	100mg	360 + 30 Pills	470.93€ 448.50€	Buy
Viagra Original	100mg	34 + 2 Pills	163.67€ 155.88€	Buy
Viagra Oral Jelly	100mg	110 + 9 Sachets	284.63€ 271.08€	Buy
Viagra Super Active	100mg	180 + 20 Pills	280.97€ 267.59€	Buy
Viagra Generic	25mg	10 Pills	25.19€ 23.99€	Buy
Viagra Generic	25mg	120 + 6 Pills	125.56€ 119.58€	Buy
Viagra Professional	100mg	180 + 4 Pills	337.30€ 321.24€	Buy
Viagra Original	100mg	8 Pills	59.84€ 56.99€	Buy
Viagra Generic	150mg	60 + 4 Pills	111.25€ 105.95€	Buy
Viagra Generic	150mg	360 + 10 Pills	423.48€ 403.31€	Buy
Viagra Generic	50mg	90 + 6 Pills	107.37€ 102.26€	Buy
Viagra Original	100mg	12 Pills	72.54€ 69.09€	Buy
Viagra Generic	100mg	90 + 6 Pills	129.02€ 122.88€	Buy
Viagra Professional	100mg	120 + 4 Pills	262.83€ 250.31€	Buy
Viagra Soft Tabs	100mg	10 Pills	36.93€ 35.17€	Buy

work if only it were designed

How to Use Scream Cream

DOI: 10.1016/j.sxmr.2016.03.002 Ad Hoc Market Research: FSAD Prevalence Report (Oct 2015) conducted for SST LLC. Based on US Census projections for 2016. Dare Bioscience developed Dare to Play, a cream boosting female sexual arousal in 10 minutes The cream contains sildenafil, the active ingredient in Viagra, increasing vaginal blood flow Clinical trials showed Dare to Play improved libido and orgasms with no side effects versus placebo Over three decades after the invention of Viagra, a little blue pill that allows men to boost their sexual performance, scientists have developed a similar alternative for women. US-based health biotech group Dare Bioscience has created a $10 a use product that works in just 10 minutes and boosts women's arousal. The first-of-its-kind cream called "Dare to Play" contains sildenafil, the same active ingredient in Viagra. and formulated specifically with women in mind and that's really where we came

Introduction: Sexual Health, Gender, and the Visibility Gap

Phase 1 and Phase 2a Clinical Studies, Previously Completed In a Phase 1 clinical study in 20 healthy post-menopausal women, topical sildenafil cream was safe and well tolerated at clinically relevant doses, and study subjects reported favorable product characteristics: easy to use and readily absorbed. In a Phase 2a study in women with FSAD (15 pre-menopausal and 16 post-menopausal), Sildenafil Cream increased measurable blood flow to the genital tissue compared to placebo cream. Further, data from a thermography study in healthy women demonstrated significantly greater increases in genital temperature after administration of Sildenafil Cream compared to placebo cream, indicating a positive impact on genital blood flow during the 30-minute testing session, with statistical separation from placebo within the first 15 minutes after dosing. We also completed a content validity study designed to identify and document the genital arousal symptoms that are the most important and relevant to women with FSAD. The findings of this study helped facilitate alignment with the FDA on acceptable efficacy endpoints for the Phase 2b RESPOND study and a future Phase 3 program.

Vaginal Itching and Menopause: Causes and Relief

The Phase 2b study was an exploratory study to evaluate a number of primary endpoints and secondary endpoints as well as to identify a target patient population for Sildenafil Cream, 3.6%. The Phase 2b clinical study was designed as a multi-center, double-blind, placebo-controlled study to evaluate the efficacy and safety of Sildenafil Cream, 3.6% in premenopausal patients with female sexual arousal disorder (FSAD). Study participants used Sildenafil Cream and placebo cream over 12 weeks in their home setting, following both a non-drug and placebo cream run-in period. All participants had a main diagnosis of FSAD and may have also had concomitant sexual dysfunction diagnoses or symptoms including decreased desire, orgasmic dysfunction, and genital pain. Exploratory Phase 2b clinical study designed to evaluate Sildenafil Cream vs. into the equation," Sabrina Martucci Johnson, president

Area	Focus	Potential Benefits
Enhanced formulation	Longer-lasting effects	Fewer applications needed
Combination products	Combining with other PDE5 inhibitors	Broader therapeutic effects
Novel delivery systems	Nanoemulsions, patches	Improved absorption, convenience
Safety profiling	Long-term studies	Better understanding of side effects

and CEO of Dare Bioscience was

• Viagra cream's popularity is growing among alternative therapies.
• It is often advertised online without regulatory approval.
• Users should research product ingredients before use.
• Topical application may reduce some systemic side effects.
• Temporary side effects include flushing and headache.
• Proper technique in application influences effectiveness.
• Avoid applying to mucous membranes or broken skin.
• Expect some changes in sensation in the applied area.
• Do not share or reuse leftover cream.
• Discuss potential interactions with healthcare providers.

quoted as saying by New York Post.

• Viagra cream offers potential for personalized dosing.
• It might be used in combinations with other topical therapies.
• Some formulations include numbing agents for comfort.
• The market is driven by demand for non-invasive ED solutions.
• Long-term safety data is currently lacking.
• Its use is often driven by convenience and privacy.
• The cream's active ingredient is usually sildenafil, similar to tablets.
• Some products claim to enhance libido beyond ED treatment.
• Use of Viagra cream does not replace professional diagnosis.
• Monitoring by healthcare providers is advised when used regularly.

But for women, comparable progress on enhancing the

OMG! Cream FAQ

Regret Regarding Fertility Preservation Decisions Among Male Cancer Patients. The Journal of Urology, 201(Supplement 4), e680-e681. Feasibility Study of Video Telehealth Clinic Visits in Urology. The Journal of Urology, 201(Supplement 4), e545-e545. Erectile dysfunction is a condition in which you have trouble getting or keeping an erection firm enough for satisfying sex.

Milrinone, a selective phosphodiesterase 3 inhibitor, stimulates lipolysis, endogenous glucose production, and insulin secretion

Erectile dysfunction affects as many as 30 million men in the United States. Premature ejaculation (PE) is a sexual dysfunction characterized by a short ejaculatory latency, a perceived lack of control about the timing of ejaculation, and distress and interpersonal difficulty related to ejaculating too quickly. Low testosterone or testosterone deficiency, also known as hypogonadism, is a condition in which patients develop symptoms such as low sex drive, erectile dysfunction (ED), and fatigue because the body doesn’t produce enough testosterone. Though many men don’t like to talk about it, ejaculation problems are very common. Some of the most common issues include premature, delayed, or retrograde ejaculation. natural arousal sensations has

Psychological Dimensions: Arousal and Embodiment

She deeply appreciates new challenges and diverse cultures on her travels. She lives in Denver with her husband, two children, and beloved Bernese Mountain Dog. You can find Dr. Brown on LinkedIn for more information. Urology Residency, University of California San Francisco Urology Residency, University of California San Francisco Northwestern University Feinberg School of MedicineB.S.

J Cosmet Las Ther

in Radiologic Science, Chemistry Minor, University of North Carolina at Chapel Hill Northwestern University Feinberg School of MedicineB.S. in Radiologic Science, Chemistry Minor, University of North Carolina at Chapel Hill Cowan, B, Walker, K., Rodgers, K., Agyemang, J. Hormonal Management Improves Semen Analysis Parameters in Men with Abnormal Concentration, Motility, and/or Morphology. Fertility and Sterility, Volume 118, Issue 5, e4. Cowan, B, Walker, K., Rodgers, K., Agyemang, J. stalled for nearly three decades."

OUR PRE-FULFILLMENT PRESCRIPTION PERIOD HAS BEGUN.

placebo over 12 weeks of double-blinded dosing following both a non-drug and placebo run-in period: Compared Sildenafil Cream vs. placebo used in patients’ home setting. Co-primary endpoints: patient reported weekend viagra outcome (PRO) instruments measured improvement in localized genital sensations of arousal (Arousal-Sensation Domain of the Sexual Function Questionnaire) and reduction in FSAD related distress (Female Sexual Distress Scale). Secondary endpoint: measured change in the number of satisfactory sexual events Exploratory endpoints: Several efficacy endpoints measured and could be candidate endpoints in a Phase 3 study. Efficacy assessments were administered both on an electronic diary to be completed within 24 hours of a sexual event and via 28-day recall assessments.

How sildenafil boosts orgasms

Sildenafil Cream-treated group showed meaningful improvement in the co‑primary endpoint assessment that evaluated change from baseline in the Arousal-Sensation Domain of the Sexual Function Questionnaire, although the endpoint did not achieve statistical significance.1 Post-hoc analyses showed that Sildenafil Cream met the Ph2b co-primary endpoint (SFQ28-arousal domain patient reported outcome (PRO)) and demonstrated clinically meaningful benefit in patients who have FSAD or FSAD with concomitant decreased desire. Secondary and exploratory endpoints saw these patients report meaningful improvement in arousal sensation, desire, orgasm, as well as stress, guilt, and embarrassment about the sexual dysfunction. Read more about the Phase 2b clinical study here. Regulatory Strategy for Sildenafil Cream, 3.6%: Next Steps The Company is working to align with the FDA on the Phase 3 study design. At the conclusion of the development program, if successful, Daré intends to leverage the existing safety and efficacy data for sildenafil to utilize the FDA’s 505(b)(2) pathway to obtain marketing approval of Sildenafil Cream, 3.6% for the treatment of women in the U.S.